• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Cell lines from MYCN transgenic murine tumours reflect the molecular and biological characteristics of human neuroblastoma.来自MYCN转基因鼠肿瘤的细胞系反映了人类神经母细胞瘤的分子和生物学特征。
Eur J Cancer. 2007 Jun;43(9):1467-75. doi: 10.1016/j.ejca.2007.03.008. Epub 2007 Apr 20.
2
Tumor development, growth characteristics and spectrum of genetic aberrations in the TH-MYCN mouse model of neuroblastoma.TH-MYCN 小鼠神经母细胞瘤模型中的肿瘤发生、生长特征和遗传异常谱。
PLoS One. 2012;7(12):e51297. doi: 10.1371/journal.pone.0051297. Epub 2012 Dec 17.
3
A Cre-conditional MYCN-driven neuroblastoma mouse model as an improved tool for preclinical studies.一种Cre条件性MYCN驱动的神经母细胞瘤小鼠模型,作为临床前研究的改进工具。
Oncogene. 2015 Jun;34(26):3357-68. doi: 10.1038/onc.2014.269. Epub 2014 Sep 1.
4
Genome-wide array CGH analysis of murine neuroblastoma reveals distinct genomic aberrations which parallel those in human tumors.小鼠神经母细胞瘤的全基因组阵列比较基因组杂交分析揭示了与人类肿瘤相似的独特基因组畸变。
Cancer Res. 2003 Sep 1;63(17):5266-73.
5
Histological profile of tumours from MYCN transgenic mice.MYCN转基因小鼠肿瘤的组织学特征
J Clin Pathol. 2008 Oct;61(10):1098-103. doi: 10.1136/jcp.2007.054627. Epub 2008 Aug 4.
6
MYCN and MYC regulate tumor proliferation and tumorigenesis directly through BMI1 in human neuroblastomas.MYCN 和 MYC 通过 BMI1 直接调节人神经母细胞瘤的肿瘤增殖和肿瘤发生。
FASEB J. 2011 Dec;25(12):4138-49. doi: 10.1096/fj.11-185033. Epub 2011 Aug 19.
7
MYCN overexpression is associated with unbalanced copy number gain, altered nuclear location, and overexpression of chromosome arm 17q genes in neuroblastoma tumors and cell lines.MYCN基因的过表达与神经母细胞瘤肿瘤及细胞系中拷贝数增加失衡、核定位改变以及17号染色体长臂基因的过表达相关。
Genes Chromosomes Cancer. 2015 Oct;54(10):616-28. doi: 10.1002/gcc.22273. Epub 2015 Jul 14.
8
MYCN gene overrepresentation detected in primary neuroblastoma tumour cells without amplification.在原发性神经母细胞瘤肿瘤细胞中检测到MYCN基因过度表达但无扩增。
J Pathol. 2002 Dec;198(4):495-501. doi: 10.1002/path.1244.
9
ODC1 is a critical determinant of MYCN oncogenesis and a therapeutic target in neuroblastoma.鸟氨酸脱羧酶1(ODC1)是MYCN致癌作用的关键决定因素,也是神经母细胞瘤的一个治疗靶点。
Cancer Res. 2008 Dec 1;68(23):9735-45. doi: 10.1158/0008-5472.CAN-07-6866.
10
A MYCN-amplified cell line derived from a long-term event-free survivor among our sixteen established neuroblastoma cell lines.从我们建立的 16 株神经母细胞瘤细胞系中,一个 MYCN 扩增的细胞系来源于一个长期无事件生存者。
Cancer Lett. 2013 Apr 30;331(1):115-21. doi: 10.1016/j.canlet.2012.12.011. Epub 2012 Dec 23.

引用本文的文献

1
Inhibition of autophagy enhances the antitumor efficacy of T/CAR T cell against neuroblastoma.自噬抑制增强了T/CAR T细胞对神经母细胞瘤的抗肿瘤疗效。
J Exp Clin Cancer Res. 2025 Jul 3;44(1):185. doi: 10.1186/s13046-025-03453-0.
2
Combining ERAP1 silencing and entinostat therapy to overcome resistance to cancer immunotherapy in neuroblastoma.联合 ERAP1 沉默和恩替诺特治疗克服神经母细胞瘤对癌症免疫治疗的耐药性。
J Exp Clin Cancer Res. 2024 Oct 22;43(1):292. doi: 10.1186/s13046-024-03180-y.
3
17q Gain in Neuroblastoma: A Review of Clinical and Biological Implications.神经母细胞瘤中17号染色体长臂增益:临床和生物学意义综述
Cancers (Basel). 2024 Jan 12;16(2):338. doi: 10.3390/cancers16020338.
4
Combined mitoxantrone and anti-TGFβ treatment with PD-1 blockade enhances antitumor immunity by remodelling the tumor immune landscape in neuroblastoma.联合米托蒽醌和抗 TGFβ 治疗与 PD-1 阻断通过重塑神经母细胞瘤的肿瘤免疫景观增强抗肿瘤免疫。
J Exp Clin Cancer Res. 2022 Nov 17;41(1):326. doi: 10.1186/s13046-022-02525-9.
5
Identification of a Vitamin-D Receptor Antagonist, MeTC7, which Inhibits the Growth of Xenograft and Transgenic Tumors .鉴定一种维生素 D 受体拮抗剂 MeTC7,它能抑制异种移植瘤和转基因肿瘤的生长。
J Med Chem. 2022 Apr 28;65(8):6039-6055. doi: 10.1021/acs.jmedchem.1c01878. Epub 2022 Apr 11.
6
NBAT1/CASC15-003/USP36 control MYCN expression and its downstream pathway genes in neuroblastoma.NBAT1/CASC15-003/USP36在神经母细胞瘤中调控MYCN表达及其下游通路基因。
Neurooncol Adv. 2021 Apr 9;3(1):vdab056. doi: 10.1093/noajnl/vdab056. eCollection 2021 Jan-Dec.
7
Dual Targeting of Chromatin Stability By The Curaxin CBL0137 and Histone Deacetylase Inhibitor Panobinostat Shows Significant Preclinical Efficacy in Neuroblastoma.通过 CBL0137 类卡宾化合物和组蛋白去乙酰化酶抑制剂帕比司他双重靶向染色质稳定性,在神经母细胞瘤的临床前研究中显示出显著疗效。
Clin Cancer Res. 2021 Aug 1;27(15):4338-4352. doi: 10.1158/1078-0432.CCR-20-2357. Epub 2021 May 16.
8
Developing preclinical models of neuroblastoma: driving therapeutic testing.开发神经母细胞瘤的临床前模型:推动治疗测试。
BMC Biomed Eng. 2019 Dec 20;1:33. doi: 10.1186/s42490-019-0034-8. eCollection 2019.
9
Combined innate and adaptive immunotherapy overcomes resistance of immunologically cold syngeneic murine neuroblastoma to checkpoint inhibition.联合先天和适应性免疫疗法克服了免疫冷型同源鼠神经母细胞瘤对检查点抑制的耐药性。
J Immunother Cancer. 2019 Dec 6;7(1):344. doi: 10.1186/s40425-019-0823-6.
10
Dextran-Catechin: An anticancer chemically-modified natural compound targeting copper that attenuates neuroblastoma growth.葡聚糖-儿茶素:一种靶向铜的抗癌化学修饰天然化合物,可抑制神经母细胞瘤生长。
Oncotarget. 2016 Jul 26;7(30):47479-47493. doi: 10.18632/oncotarget.10201.

本文引用的文献

1
Regions syntenic to human 17q are gained in mouse and rat neuroblastoma.与人类17号染色体长臂同源的区域在小鼠和大鼠神经母细胞瘤中出现扩增。
Genes Chromosomes Cancer. 2004 Jun;40(2):158-63. doi: 10.1002/gcc.20031.
2
MYCN-mediated regulation of the MRP1 promoter in human neuroblastoma.MYCN介导的人类神经母细胞瘤中多药耐药相关蛋白1(MRP1)启动子的调控
Oncogene. 2004 Jan 22;23(3):753-62. doi: 10.1038/sj.onc.1207151.
3
Genome-wide array CGH analysis of murine neuroblastoma reveals distinct genomic aberrations which parallel those in human tumors.小鼠神经母细胞瘤的全基因组阵列比较基因组杂交分析揭示了与人类肿瘤相似的独特基因组畸变。
Cancer Res. 2003 Sep 1;63(17):5266-73.
4
Effects of MYCN antisense oligonucleotide administration on tumorigenesis in a murine model of neuroblastoma.MYCN反义寡核苷酸给药对神经母细胞瘤小鼠模型肿瘤发生的影响。
J Natl Cancer Inst. 2003 Sep 17;95(18):1394-403. doi: 10.1093/jnci/djg045.
5
A role for distinct cell types in determining malignancy in human neuroblastoma cell lines and tumors.不同细胞类型在确定人类神经母细胞瘤细胞系和肿瘤的恶性程度中的作用。
Cancer Lett. 2003 Jul 18;197(1-2):35-9. doi: 10.1016/s0304-3835(03)00079-x.
6
Neuroblastoma: biological insights into a clinical enigma.神经母细胞瘤:对临床谜题的生物学见解
Nat Rev Cancer. 2003 Mar;3(3):203-16. doi: 10.1038/nrc1014.
7
Expression of N-myc and MRP genes and their relationship to N-myc gene dosage and tumor formation in a murine neuroblastoma model.N-myc和MRP基因的表达及其在小鼠神经母细胞瘤模型中与N-myc基因剂量和肿瘤形成的关系。
Med Pediatr Oncol. 2000 Dec;35(6):585-9. doi: 10.1002/1096-911x(20001201)35:6<585::aid-mpo20>3.0.co;2-p.
8
Genome-wide screen for allelic imbalance in a mouse model for neuroblastoma.神经母细胞瘤小鼠模型中等位基因不平衡的全基因组筛选。
Cancer Res. 2000 May 1;60(9):2483-7.
9
Gain of chromosome arm 17q and adverse outcome in patients with neuroblastoma.神经母细胞瘤患者17号染色体长臂获得与不良预后
N Engl J Med. 1999 Jun 24;340(25):1954-61. doi: 10.1056/NEJM199906243402504.
10
Altered expression of the MYCN oncogene modulates MRP gene expression and response to cytotoxic drugs in neuroblastoma cells.MYCN癌基因表达的改变可调节神经母细胞瘤细胞中MRP基因的表达及对细胞毒性药物的反应。
Oncogene. 1999 Apr 29;18(17):2777-82. doi: 10.1038/sj.onc.1202859.

来自MYCN转基因鼠肿瘤的细胞系反映了人类神经母细胞瘤的分子和生物学特征。

Cell lines from MYCN transgenic murine tumours reflect the molecular and biological characteristics of human neuroblastoma.

作者信息

Cheng Andy J, Cheng Ngan Ching, Ford Jette, Smith Janice, Murray Jayne E, Flemming Claudia, Lastowska Maria, Jackson Michael S, Hackett Christopher S, Weiss William A, Marshall Glenn M, Kees Ursula R, Norris Murray D, Haber Michelle

机构信息

Children's Cancer Institute Australia for Medical Research, P.O. Box 81, Randwick, 2031 Sydney, Australia.

出版信息

Eur J Cancer. 2007 Jun;43(9):1467-75. doi: 10.1016/j.ejca.2007.03.008. Epub 2007 Apr 20.

DOI:10.1016/j.ejca.2007.03.008
PMID:17449239
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3000537/
Abstract

Overexpression of the human MYCN oncogene driven by a tyrosine hydroxylase promoter causes tumours in transgenic mice that recapitulate the childhood cancer neuroblastoma. To establish an in vitro model to study this process, a series of isogenic cell lines were developed from these MYCN-driven murine tumours. Lines were established from tumours arising in homozygous and hemizygous MYCN transgenic mice. Hemizygous tumours gave rise to cell lines growing only in suspension. Homozygous tumours gave rise to similar suspension lines as well as morphologically distinct substrate-adherent lines characteristic of human S-type neuroblastoma cells. FISH analysis demonstrated selective MYCN transgene amplification in cell lines derived from hemizygous mice. Comparative genomic hybridisation (CGH) and fluorescence in situ hybridisation (FISH) analysis confirmed a range of neuroblastoma-associated genetic changes in the various lines, in particular, gain of regions syntenic with human 17q. These isogenic lines together with the transgenic mice thus represent valuable models for investigating the biological characteristics of aggressive neuroblastoma.

摘要

由酪氨酸羟化酶启动子驱动的人类MYCN癌基因过表达会在转基因小鼠中引发肿瘤,这些肿瘤重现了儿童癌症神经母细胞瘤的特征。为了建立一个体外模型来研究这一过程,从这些由MYCN驱动的小鼠肿瘤中培育出了一系列同基因细胞系。细胞系是从纯合和半合子MYCN转基因小鼠产生的肿瘤中建立的。半合子肿瘤产生的细胞系只能在悬浮状态下生长。纯合子肿瘤产生了类似的悬浮细胞系以及形态上不同的贴壁细胞系,这些细胞系具有人类S型神经母细胞瘤细胞的特征。荧光原位杂交(FISH)分析表明,在源自半合子小鼠的细胞系中存在选择性MYCN转基因扩增。比较基因组杂交(CGH)和荧光原位杂交(FISH)分析证实,各个细胞系中存在一系列与神经母细胞瘤相关的基因变化,特别是与人类17q同线的区域增加。因此,这些同基因细胞系与转基因小鼠一起代表了研究侵袭性神经母细胞瘤生物学特性的宝贵模型。